Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Name: Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Author: Grassi, Paolo

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? — المؤلف: Grassi, Paolo — Drugs in R&D 20180628

المؤلف: Grassi, Paolo
النشر: Drugs in R&D 20180628
الوصف: 461-467 p.
الموضوعات: Angiogenesis Inhibitors؛ Carcinoma, Renal Cell؛ Disease-Free Survival؛ Dose-Response Relationship, Drug؛ Female؛ Follow-Up Studies؛ Humans؛ Indazoles